Glycitop MR Tablet (Gliclazide Modified Release) | Used for Type 2 Diabetes and Blood Sugar Control
Glycitop MR Tablet (Gliclazide Modified Release) is a sulphonylurea antidiabetic medicine used to control blood sugar levels in type 2 diabetes mellitus. Once-daily modified-release formula provides stable and long-lasting glucose control.
Product Overview
Glycitop MR Tablet is a high-precision second-generation sulfonylurea containing Gliclazide in a Modified Release (MR) formulation. Glycitop MR Tablet is a primary therapeutic agent designed for the management of Type 2 Diabetes Mellitus. The "Modified Release" technology ensures a controlled and gradual delivery of the active ingredient over 24 hours, mimicking the body’s physiological insulin response and maintaining stable glycemic control without the frequent "peaks" associated with immediate-release versions.
Product Composition
- Active Ingredient: Gliclazide
- Pharmacological Class: Second-Generation Sulfonylurea
- Formulation: Modified Release (MR) Tablet
- Common Strengths: 30 mg, 60 mg & 80 mg
- Excipients: May include hypromellose, lactose monohydrate, and magnesium stearate
Product Specifications
| Feature | Specification |
| Drug Category | Oral Hypoglycemic Agent |
| Therapeutic Class | Antidiabetic |
| Release Profile | Controlled 24-hour release |
| Metabolism | Hepatic (Liver) |
| Storage | Store below 30°C in a dry place |
Mechanism of Action
- Insulin Secretion Stimulant: Gliclazide works by binding to specific sulfonylurea receptors (SUR1) on the surface of pancreatic beta cells. This triggers the closure of ATP-sensitive potassium channels, leading to the release of stored insulin.
- Restoration of First-Phase Insulin: It helps restore the "first phase" of insulin secretion, which is often lost in patients with Type 2 Diabetes, thereby reducing postprandial glucose spikes.
- Peripheral Sensitivity: It modestly improves the sensitivity of peripheral tissues (like muscle and fat) to insulin, aiding in more efficient glucose uptake.
- Haemovascular Properties: Unique among sulfonylureas, Gliclazide exhibits antioxidant properties and reduces the "stickiness" of platelets, which may help protect small blood vessels from diabetic complications.
Key Benefits
- Steady 24-Hour Coverage: The Modified Release matrix provides a consistent blood-sugar-lowering effect, allowing for a convenient once-daily dosing schedule.
- Reduced Hypoglycemia Risk: Because the drug is released gradually, the risk of sudden "crashes" in blood sugar (hypoglycemia) is lower compared to standard Gliclazide tablets.
- Effective HbA1c Reduction: Highly reliable in helping patients reach their long-term HbA1c targets and maintaining metabolic stability.
- Weight Neutrality: Clinical studies often show that Gliclazide has a more favorable weight profile compared to other sulfonylureas.
- Cardiovascular Safety: It is well-regarded for its safety profile in older patients and those with a higher risk of vascular issues due to its specific action on pancreatic receptors.
Usage
Glycitop MR Tablet is a precision-engineered modified-release antidiabetic medication. The unique matrix formulation requires specific administration timing to synchronize the medication’s peak effect with the body’s glucose intake, ensuring optimal glycemic regulation throughout the day.
Dosage and Administration
Adhering to these clinical protocols is vital to ensure the sustained-release mechanism operates correctly and provides a steady hypoglycemic effect.
Administration Timing: The tablet must be taken once daily at breakfast time. Taking the medication with the first meal of the day ensures that the drug concentration aligns with the day's nutritional intake.
Tablet Integrity: The tablet should be swallowed whole with a glass of water. Do not crush or chew the tablet, as breaking the modified-release matrix will cause the entire dose to be released at once, increasing the risk of hypoglycemia.
Meal Consistency: It is crucial not to skip meals while taking Glycitop MR. Because the medication stimulates insulin release, skipping a meal after taking the dose can lead to a dangerous drop in blood sugar.
Blood Sugar Monitoring: Regular testing of fasting blood glucose and post-meal levels is necessary to confirm the dosage is providing adequate control.
Missed Dose: If a dose is missed, it should be skipped entirely if it is already late in the day. Resume the regular schedule the following morning at breakfast. Never take a double dose to make up for a missed one.
Precautions: Avoid excessive alcohol consumption, as it can mask the symptoms of low blood sugar and interfere with glucose metabolism.
Uses
Glycitop MR Tablet is indicated for the long-term metabolic management of adults, focusing on the prevention of chronic complications through stable glucose homeostasis.
Primary Therapeutic Uses
Management of Type 2 Diabetes Mellitus: Indicated for patients whose blood sugar levels are not sufficiently controlled by diet, physical exercise, and weight reduction alone.
Targeted HbA1c Reduction: Specifically used to lower long-term average blood glucose levels to prevent the progression of diabetic symptoms.
Control of Postprandial Hyperglycemia: Helps regulate the insulin response immediately following meals, preventing sharp sugar spikes.
Maintenance of Fasting Glucose: Ensures the pancreas maintains a steady basal level of insulin to control glucose production by the liver during periods of rest.
Prevention of Microvascular Complications: By maintaining tight glycemic control, it helps reduce the risk of long-term damage to the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy).
Combination Therapy: Often used in conjunction with other antidiabetic agents, such as Metformin, when monotherapy is no longer sufficient to reach clinical targets.
Haemovascular Protection: Utilized for its unique ability to reduce platelet aggregation and oxidative stress, supporting overall vascular health in diabetic patients.
Side effects
Common side effects
- Low blood sugar (hypoglycemia)
- Headache
- Dizziness
- Nausea
- Weight gain
- Weakness or fatigue
Digestive system effects
- Stomach discomfort
- Indigestion
- Loss of appetite
- Mild vomiting
Skin reactions
- Rash
- Itching
- Sweating
- Mild allergic reactions
General effects
- Trembling
- Excess hunger
- Irritability
- Blurred vision (during low sugar episodes)
Serious side effects (rare)
| Serious effect | Possible signs |
|---|---|
| Severe hypoglycemia | Confusion, fainting, seizures |
| Severe allergy | Swelling, rash, breathing difficulty |
| Blood disorders | Frequent infections, unusual bruising |
| Liver problems | Yellow skin, dark urine, fatigue |
Important warning
- Stop use and seek immediate attention if serious symptoms occur
- Watch closely for signs of low blood sugar
- Regular blood sugar monitoring helps reduce risks during treatment
FAQs
Q: What is Glycitop MR Tablet used for?
A: Glycitop MR Tablet is used to control blood sugar levels in adults with type 2 diabetes mellitus. It is used when diet, exercise, and weight reduction alone are not enough to control blood sugar levels adequately.
Q: What does Modified Release (MR) mean in Glycitop MR Tablet?
A: Modified Release means the tablet releases Gliclazide slowly and progressively throughout the day. This provides stable and consistent blood sugar control with a single daily dose and reduces the risk of hypoglycaemia compared to immediate-release formulations.
Q: How does Glycitop MR Tablet work?
A: Gliclazide works by stimulating the pancreas to produce and release more insulin. It also helps the body use insulin more efficiently. This lowers blood sugar levels and helps maintain long-term glucose control as measured by HbA1c.
Q: How should Glycitop MR Tablet be taken?
A: Take it once daily at breakfast time with a glass of water. Always eat a meal after taking the tablet. Swallow it whole and do not crush, chew, or break it as this will affect its modified-release properties. Take it at the same time each day for best results.
Q: What are the common side effects of Glycitop MR Tablet?
A: Common side effects include low blood sugar (hypoglycaemia), nausea, stomach upset, diarrhoea, and skin rash. Most are mild and resolve on their own. Consult your doctor if they persist or worsen.
Q: Can Glycitop MR Tablet cause low blood sugar (hypoglycaemia)?
A: Yes, hypoglycaemia is the most common side effect of Glycitop MR Tablet. The risk is higher if you skip or delay meals, exercise excessively, or drink alcohol. Always carry glucose tablets or sugar candies with you in case of a sudden drop in blood sugar.
Q: Who should not take Glycitop MR Tablet?
A: Avoid if you are allergic to Gliclazide or other sulphonylureas. Also avoid if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or are taking antifungal medicines such as miconazole.
Q: Can Glycitop MR Tablet be used during pregnancy?
A: No, Glycitop MR Tablet is not recommended during pregnancy. Insulin is the preferred treatment for diabetes during pregnancy. Consult your doctor before taking this medicine if you are pregnant or planning to become pregnant.
Q: Is Glycitop MR Tablet safe during breastfeeding?
A: Glycitop MR Tablet is not recommended during breastfeeding. Consult your doctor before taking this medicine while breastfeeding.
Q: Can Glycitop MR Tablet be used in children?
A: No, the safety and effectiveness of Glycitop MR Tablet in children and adolescents have not been established. It is recommended for use in adults only.
Q: Can Glycitop MR Tablet be used in elderly patients?
A: Yes, it can be used in elderly patients. The starting dose is 30mg daily even in elderly patients. Close monitoring of blood sugar levels is advisable as elderly patients may be more sensitive to hypoglycaemia.
Q: Can I drink alcohol while taking Glycitop MR Tablet?
A: Avoid alcohol while taking Glycitop MR Tablet as it may increase the risk of hypoglycaemia and cause unpredictable changes in blood sugar levels.
| Manufacturer | : | Healing Pharma |
| Trade Name | : | Diamicron |
| Generic Search | : | Gliclazide |
| Strength | : | 30mg, 60mg, 80mg |
Latest Products
